Overview
The purpose of this study is to evaluate the effectiveness of using virtual reality to treat gastrointestinal symptoms related to functional dyspepsia.
Eligibility
Inclusion Criteria:
- Symptoms of dyspepsia thought to represent functional dyspepsia, meeting Rome IV criteria
- Had an upper endoscopy and assessment for Helicobacter pylori; if a patient is found to have H. pylori, treatment with confirmed eradication (by stool antigen test or urea breath test) will be required before the patient is eligible for study inclusion.
- Patients will be considered for the study if they have undergone a complete history and physical examination during a previously scheduled consultation/evaluation visit with a gastroenterologist in the Mayo Clinic Florida General GI or Motility clinic.
Exclusion Criteria:
- Symptoms are thought to represent an organic disorder (e.g., peptic ulcer disease, hepatitis, pancreatitis, inflammatory bowel disease, type I diabetes, a known malignancy, radiation-induced injury, an active infection, vasculitis, celiac disease), or patients have known uncontrolled GERD, esophagitis, eosinophilic esophagitis, or untreated H. pylori.
- Patients with gastroparesis or cyclic vomiting syndrome.
- Patients with prior surgery to the esophagus, stomach or duodenum.
- Patients taking opioids.
- Patients with motion sickness, vertigo, or a seizure disorder
- IBS symptoms are not predominant.